Probiotics and diarrhea
Pro Research Analysisby 
Searched over 200M research papers
Probiotics and Diarrhea: Efficacy and Safety
Introduction to Probiotics and Diarrhea
Probiotics, live microorganisms that confer health benefits to the host, have been extensively studied for their potential to prevent and treat various forms of diarrhea, including antibiotic-associated diarrhea (AAD) and acute infectious diarrhea. This article synthesizes findings from multiple studies to provide a comprehensive overview of the efficacy and safety of probiotics in managing diarrhea.
Probiotics for Preventing Antibiotic-Associated Diarrhea (AAD)
Efficacy in Children
Several studies have demonstrated that probiotics can significantly reduce the incidence of AAD in children. A meta-analysis of 33 studies involving 6,352 participants found that probiotics reduced the incidence of AAD from 19% in the control group to 8% in the probiotic group, with a risk ratio (RR) of 0.45. High-dose probiotics (≥ 5 billion CFUs per day) were particularly effective, reducing the incidence to 8% compared to 23% in the control group. Another review recommended the use of Lactobacillus rhamnosus GG and Saccharomyces boulardii for preventing AAD in children, citing moderate quality evidence.
Efficacy in Adults and Children
Probiotics have also been shown to be effective in preventing Clostridium difficile-associated diarrhea (CDAD) in both adults and children. A systematic review of 31 trials with 8,672 participants found that probiotics reduced the incidence of CDAD by 60%, with an RR of 0.40. The benefit was more pronounced in high-risk groups, where the baseline risk of CDAD was greater than 5%.
Probiotics for Treating Acute Infectious Diarrhea
Reduction in Duration and Severity
Probiotics have been found to be beneficial in reducing the duration and severity of acute infectious diarrhea. A review of 63 studies involving 8,014 participants showed that probiotics reduced the mean duration of diarrhea by approximately 24.76 hours and decreased stool frequency on the second day of treatment. Another study confirmed these findings, noting that probiotics reduced the duration of diarrhea by nearly one day.
Specific Strains and Mechanisms
Lactobacillus casei has been shown to be effective in managing childhood diarrhea by altering gut microbiota and reducing fecal inflammatory markers such as lactoferrin and calprotectin. This strain, along with others like Lactobacillus rhamnosus GG and Saccharomyces boulardii, has been consistently recommended for their efficacy in treating diarrhea .
Safety of Probiotics
Adverse Events
The safety profile of probiotics is generally favorable. In studies involving children, no serious adverse events were attributed to probiotics, and common side effects were mild, including rash, nausea, and abdominal bloating. Similarly, a review of 32 studies found that probiotics reduced the risk of adverse events by 17%, with no serious adverse events reported.
Special Populations
While probiotics are safe for most populations, caution is advised for severely debilitated or immunocompromised individuals. Observational studies have reported serious adverse events in such populations, particularly those with central venous catheters or conditions associated with bacterial/fungal translocation.
Conclusion
Probiotics, particularly strains like Lactobacillus rhamnosus GG and Saccharomyces boulardii, are effective in preventing and treating various forms of diarrhea, including AAD and acute infectious diarrhea. They are generally safe for use in children and adults, with a low incidence of mild adverse events. However, further research is needed to confirm the efficacy and safety of other probiotic strains and to establish standardized guidelines for their use in specific patient groups.
Sources and full results
Most relevant research papers on this topic